Woodline Partners LP Lava Therapeutics Nv Transaction History

Woodline Partners LP

  • $11 Billion
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2021

Nov 15, 2021
SELL
$5.5 - $11.0 $477,972 - $955,944
-86,904 Closed
0 $0
Q2 2021

Aug 16, 2021
SELL
$10.8 - $16.0 $284,450 - $421,408
-26,338 Reduced 23.26%
86,904 $946,000
Q1 2021

May 17, 2021
BUY
$12.5 - $15.19 $1.42 Million - $1.72 Million
113,242 New
113,242 $1.72 Million

Others Institutions Holding LVTX

# of Institutions
28
Shares Held
3.61M
Call Options Held
32.9K
Put Options Held
500
View Full List

About LAVA Therapeutics NV

LVTX Quotes by TradingView
  • Ticker LVTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 25,797,700
  • Market Cap $26.8M
  • Description
  • LAVA Therapeutics N.V., a clinical-stage immuno-oncology company, focuses on developing cancer treatments. The company, through its Gammabody platform, develops a portfolio of novel bispecific antibodies to engage and leverage the potency and precision of gamma delta T cells to elicit an anti-tumor immune response and enhance outcomes for cancer...
More about LVTX
Track This Portfolio

Track Woodline Partners LP Portfolio

Follow Woodline Partners LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Woodline Partners LP, based on Form 13F filings with the SEC.

News

Stay updated on Woodline Partners LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email